Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gun Park

Showing results (291-300 of 318) with videos related to

Pageof 32
Sort By:
JACC. Advances|August 21, 2025
Medical Intensive Care Unit Overflow Into the Cardiac Intensive Care Unit: Insights From CCCTN RegistryAmeesh Isath, Atul Bali, Uzair A Mahmood, et al.
Circulation|May 25, 2026
Lipoprotein(a) Levels, Risk of Cardiovascular Events and Benefit of Evolocumab: Findings From the VESALIUS-CV TrialVictorien Monguillon, Nicholas A Marston, Erin A Bohula, et al.
Lancet (London, England)|September 2, 2017
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trialRobert P Giugliano, Terje R Pedersen, Jeong-Gun Park, et al.
Extracellular Vesicle|June 17, 2025
Plasma extracellular vesicle cargo microRNAs are associated with heart failure and cardiovascular death following acute coronary syndromeWorawan B Limpitikul, Michael G Silverman, Nedyalka Valkov, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 3, 2026
Vacancy-Suppressed Garnet Electrolytes for Durable Solid-State BatteriesSeokjae Hong, Kwang Ho Shin, Kyoung Sun Kim, et al.
Critical Care Explorations|November 25, 2020
Advanced Respiratory Support in the Contemporary Cardiac ICUThomas S Metkus, P Elliott Miller, Carlos L Alviar, et al.
JAMA|March 28, 2026
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV TrialNicholas A Marston, Erin A Bohula, Ajay K Bhatia, et al.
Journal of Intensive Medicine|September 11, 2025
Anemia as a potent marker of in-hospital mortality in patients admitted to the cardiac intensive care unit: Data from the Critical Care Cardiology Trials Network (CCCTN) RegistryChristine Chow, Rasheed Durowoju, Carlos Alviar, et al.
JACC. Advances|August 13, 2024
Characteristics and Outcomes of Adults With Congenital Heart Disease in the Cardiac Intensive Care UnitRyan R Keane, Anthony P Carnicelli, Daniel B Loriaux, et al.
European Heart Journal. Acute Cardiovascular Care|February 8, 2022
A pragmatic lab-based tool for risk assessment in cardiac critical care: data from the Critical Care Cardiology Trials Network (CCCTN) RegistrySiddharth M Patel, Jacob C Jentzer, Carlos L Alviar, et al.
Pageof 32

Showing results (291-300 of 318) with videos related to

Sort By:
Pageof 32
JACC. Advances|August 21, 2025
Medical Intensive Care Unit Overflow Into the Cardiac Intensive Care Unit: Insights From CCCTN RegistryAmeesh Isath, Atul Bali, Uzair A Mahmood, et al.
Circulation|May 25, 2026
Lipoprotein(a) Levels, Risk of Cardiovascular Events and Benefit of Evolocumab: Findings From the VESALIUS-CV TrialVictorien Monguillon, Nicholas A Marston, Erin A Bohula, et al.
Lancet (London, England)|September 2, 2017
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trialRobert P Giugliano, Terje R Pedersen, Jeong-Gun Park, et al.
Extracellular Vesicle|June 17, 2025
Plasma extracellular vesicle cargo microRNAs are associated with heart failure and cardiovascular death following acute coronary syndromeWorawan B Limpitikul, Michael G Silverman, Nedyalka Valkov, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 3, 2026
Vacancy-Suppressed Garnet Electrolytes for Durable Solid-State BatteriesSeokjae Hong, Kwang Ho Shin, Kyoung Sun Kim, et al.
Critical Care Explorations|November 25, 2020
Advanced Respiratory Support in the Contemporary Cardiac ICUThomas S Metkus, P Elliott Miller, Carlos L Alviar, et al.
JAMA|March 28, 2026
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV TrialNicholas A Marston, Erin A Bohula, Ajay K Bhatia, et al.
Journal of Intensive Medicine|September 11, 2025
Anemia as a potent marker of in-hospital mortality in patients admitted to the cardiac intensive care unit: Data from the Critical Care Cardiology Trials Network (CCCTN) RegistryChristine Chow, Rasheed Durowoju, Carlos Alviar, et al.
JACC. Advances|August 13, 2024
Characteristics and Outcomes of Adults With Congenital Heart Disease in the Cardiac Intensive Care UnitRyan R Keane, Anthony P Carnicelli, Daniel B Loriaux, et al.
European Heart Journal. Acute Cardiovascular Care|February 8, 2022
A pragmatic lab-based tool for risk assessment in cardiac critical care: data from the Critical Care Cardiology Trials Network (CCCTN) RegistrySiddharth M Patel, Jacob C Jentzer, Carlos L Alviar, et al.
Pageof 32